What is the Buying Price of Wockhardt Share?

The Buying Price of Wockhardt share is 2152.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Wockhardt Share at Choice?

To buy Wockhardt stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Wockhardt, choose your preferred order type, and place the trade.

What is the PE ratio of Wockhardt Shares?

The Price-to-earnings (P/E) ratio of Wockhardt shares is 154.92. You can compare it with the sector average for relative valuation.

What is the PB ratio of Wockhardt Shares?

The Price to Book (P/B) ratio Wockhardt shares is 6.68. Useful to assess the stock's value relative to its book value.

Is Wockhardt Overvalued?

To assess Wockhardt’s valuation compare Sector P/E, P/B which are 69.53 & 2.99 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Wockhardt?

The Market Cap of Wockhardt is 34982.94 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Wockhardt Share Price?

The 52 week high and low prices of Wockhardt share price is 2422.3 & 1086.7. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Wockhardt belong to?

Wockhardt belongs to the Healthcare sector.

Wockhardt Share price

WOCKPHARMA

Healthcare Large Cap

2152.9

121.50 (5.98%)

NSE

BSE

Last updated on 1 Jun, 2026 | 15:58 IST

BUYSELL

Today's High

2422.30

Today's Low

2126.40

52 Week Low

1086.70

52 Week High

2422.30

Free Demat with Zero AMC*

Wockhardt Chart

ChartIQ

TradingView

Wockhardt Share Key Metrics

Volume

1.18 CR

Market Cap

34982.94 CR

LTQ@LTP

1@2152.90

ATP

2244.79

Var Margin

25.53 %

Circuit Range

1625.2-2437.6

Delivery %

16.7 %

Value

2650.29 CR

ASM/GSM

No

Market Lot

1

Summary

1 Jun, 2026 | 15:58 को, Wockhardt का शेयर प्राइस आज ₹2152.9 पर है, जो दिन के लिए 121.50% की 5.98 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹2126.40 और ₹2422.30 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1086.70 से ₹2422.30 तक रही है। ट्रेडिंग गतिविधि के मामले में, Wockhardt ने 11806406 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹162492169 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹224479 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 1,215290 रही। यह स्टॉक ₹1625.2-2437.6 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹2650.29 CR है। दिन के लिए डिलीवरी परसेंटेज 16.7% रही। इसके अतिरिक्त, Wockhardt वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Wockhardt Fundamentals

P/E Ratio

154.92

P/B Ratio

6.68

Div. Yield

0

Sector P/E

69.53

Sector P/B

2.99

Sec. Div. Yield

0.55

Wockhardt Resistance and Support

Pivot 2000.3

Resistance

First Resistance

2128.5

Second Resistance

2225.6

Third Resistance

2353.8

Support

First Support

1903.2

Second Support

1775

Third Support

1677.9

Wockhardt Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

49.08%

Mutual Fund

8.12%

Insurance

0.06%

Foreign Institutional Investors

7.08%

Domestic Institutional Investors

2.81%

Retail

32.84%

Others

0.01%

Total Promoters

MAR '26

49.08%

Wockhardt Corporate Actions

Date	Agenda
2026-05-04	Audited Results & Others
2026-02-10	Quarterly Results

Wockhardt News

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Wockhardt Limited will hold an Investor Meet on June 4, 2026, at NSE Exchange Plaza, BKC. The meet will include presentations on strategic overview, Zaynich US, and Zaynich India businesses, followed by a Q&A session with key management personnel.

Jun 01 2026 20:31:54

Wockhardt among 8 stocks hit 52-week highs, rally up to 55% in a month

Wockhardt's stock reached a 52-week high, rallying up to 55% over the past month, demonstrating strong performance despite a 508-point fall in the benchmark Sensex.

Jun 01 2026 17:40:02

Wockhardt shares in focus after FDA approval for antibiotic targeting drug-resistant infections. Check details

Wockhardt announced that the U.S. Food and Drug Administration (FDA) has approved its novel intravenous antibiotic, ZAYNICH (cefepime and zidebactam), for treating complicated urinary tract infections (UTI) in adults. This approval addresses the significant public health challenge of antimicrobial resistance, particularly for infections caused by susceptible Gram-negative pathogens.

Jun 01 2026 08:46:59

Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details

Wockhardt has received US FDA approval for its novel intravenous antibiotic, ZAYNICH (cefepime and zidebactam), for the treatment of complicated urinary tract infections (UTI), including pyelonephritis, caused by multidrug-resistant Gram-negative bacteria. This approval is a significant milestone for the company's innovation in combating antimicrobial resistance and positions the drug for a substantial market opportunity.

Jun 01 2026 08:46:59

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Wockhardt received U.S. FDA approval for ZAYNICH™, a novel intravenous antibiotic used to treat complicated urinary tract infections. This approval provides a new option for patients with multidrug-resistant Gram-negative bacteria.

May 30 2026 18:21:39

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Wockhardt has received marketing authorization from the Central Drugs Standard Control Organisation (CDSCO) for its breakthrough antibiotic, Zaynich® (Zidebactam/Cefepime). This approval targets complicated urinary tract infections including pyelonephritis with Gram-negative bacteremia.

May 28 2026 09:16:15

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Credit Rating

ICRA Limited has upgraded Wockhardt's credit ratings. Long-term instruments are now rated 'A- (Stable)' and short-term instruments 'A2+'. This upgrade reflects the company's improved financial performance and market position.

May 21 2026 14:39:33

Wockhardt shares jump 10% after profitability returns in Q4, margins expand on revenue growth

Wockhardt reported a significant financial turnaround in Q4 FY26, posting a consolidated net profit of ₹166 crore, reversing a net loss of ₹25 crore from the previous year. The company's revenue increased by 30% year-on-year to ₹965 crore, driven by robust growth in biotech operations and key markets, with EBITDA margins expanding to 20.3%.

May 05 2026 12:19:55

Wockhardt shares jump 9% after strong Q4 turnaround, robust FY26 growth

Wockhardt shares surged 9% following a strong turnaround in its March quarter performance. The company reported a positive net profit and substantial revenue growth, with full-year earnings also improving. Key drivers included biotech operations and expansion in emerging markets, alongside new product filings and approvals.

May 05 2026 09:48:31

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Wockhardt received a monitoring report from CRISIL for Q4 FY26 confirming no deviation in the utilization of QIP proceeds. However, Rs. 162.33 crore allocated for capital expenditure and R&D will now be utilized by FY2028, extending the original timeline.

May 04 2026 18:44:36

Name	Position
Rashmi Mamtura	Company Secretary & Compliance Officer
Habil Khorakiwala	Chairman

Wockhardt Similar Stocks

Aster DM Healthcare Ltd.

720.95

-7.40 (1.02%)

Glaxosmithkline Pharmaceuticals Ltd.

2204.40

-5.80 (0.26%)

Gland Pharma Ltd.

2292.40

42.40 (1.88%)

Ajanta Pharma Ltd.

2931.00

2.10 (0.07%)

JB Chemicals & Pharmaceuticals Ltd.

2140.20

-27.20 (1.25%)

Emcure Pharmaceuticals Ltd.

1705.20

9.20 (0.54%)

Global Health Ltd.

1168.80

-20.20 (1.70%)

Krishna Institute of Medical Sciences Ltd

753.90

-4.95 (0.65%)

Dr. Lal Pathlabs Ltd.

1577.30

-30.10 (1.87%)

Acutaas Chemicals Ltd.

3018.90

-113.60 (3.63%)

Wockhardt FAQs

Wockhardt शेयर का खरीद मूल्य 2152.9 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Wockhardt शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Wockhardt शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 154.92 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Wockhardt शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 6.68 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Wockhardt शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.99 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Wockhardt का मार्केट कैप 34982.94 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Wockhardt शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 2422.30 और 1086.70 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।